Events

Brandal SHB, Mo T, Fangberget A, Nilsen LB, Geier OM, Bjørndal H, Holmen MM, Engebråten O, Garred Ø, Hole KH, Seierstad T (2026)
MRI for Predicting Response and 10-Year Outcome of Neoadjuvant Chemotherapy with or Without Additional Bevacizumab Treatment in HER2-Negative Breast Cancer
Cancers (Basel), 18 (3)
DOI 10.3390/cancers18030393, PubMed 41681863

Hjorth S, Vandraas KF, Trewin-Nybråten CB, Botteri E, Ursin G, Andreassen BK, Støer NC (2026)
Anti-HER2 treatment in everyday practice: how we treat older women with breast cancer differently
Breast Cancer Res Treat, 215 (2), 54
DOI 10.1007/s10549-025-07888-z, PubMed 41498846

Husby M, Frydenberg H, Myklebust TÅ, Skei NV, Solligård E, Thune I, Gustad LT, Furberg AS (2026)
Cancer Patients with Sepsis: Prognostic Insights from a Population-Based Cohort Study in Norway
Cancer Epidemiol Biomarkers Prev, 35 (2), 264-275
DOI 10.1158/1055-9965.EPI-25-1018, PubMed 41324403